Impact ledger
Imara Inc. (IRON): the developments shaping its investment case
Follow the evidence affecting Imara Inc.'s financing assumptions. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.
Test assumptions, examine opportunities, and save your research.
Material developments
Evidence affecting valuation assumptions
Each entry names the assumption the evidence touches and how the evidence reads. Direction describes the business mechanism, not a stock-price conclusion.
| Date | Assumption | Direction | Interpretation |
|---|---|---|---|
| 2026-06-30 | wacc | Bullish | Higher cost-of-debt tranche lifts blended WACC. |
| 2026-06-30 | interest_expense | Bullish | High-yield coupon materially raises interest burden. |
| 2026-06-30 | net_debt | Bullish | Sub-IG debt raise increases leverage and net debt. |
Event impact log
2 events mapped to IRON since 2026-09-01. Evidence through 2026-09-01.
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-09-01 | Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026 | Indirect competitive landscape shift in hematologic disorders, particularly myelofibrosis, if DISC-0974 data is compelling. | watch | 1-3m | 0.40 |
| 2026-09-01 | Disc Medicine to Present Phase 2 RESTORE-PV and RALLY-MF Trial Data at SOHO | Indirect competitive pressure or validation of therapeutic approach in myelofibrosis and polycythemia vera markets. | watch | 1-3m | 0.30 |
Continue this research
Build your Imara Inc. investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.
This ledger is regenerated from Market Ontology's public event pipeline. View the IRON entity page →